These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Viability and ultrastructure of S. aureus treated with fosfomycin. Schmid EN. Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1983 Feb; 253(4):476-88. PubMed ID: 6858443 [Abstract] [Full Text] [Related]
43. Effects of changes in pH, medium and inoculum size on the in vitro activity of different quinolone and fluoroquinolone antibiotics against urinary pathogens. Gesu GP, Eftimiadi C, Debbia E, Schito GC. Drugs Exp Clin Res; 1987 Feb; 13(2):79-84. PubMed ID: 3556122 [Abstract] [Full Text] [Related]
44. Evolution of sensitivity to fosfomycin in bacteria isolated in 1973, 1974 and 1975 in the Servicio de Microbiologia y Epidemiologia of the 'Clinica Puerta de Hierro', Madrid. Dámaso D, Moreno-López M, Martínez-Beltrán J. Chemotherapy; 1977 Feb; Suppl 1():104-11. PubMed ID: 832509 [Abstract] [Full Text] [Related]
45. Correlation between ability of Ornithobacterium rhinotracheale to agglutinate red blood cells and susceptibility to fosfomycin. Fitzgerald SL, Greyling JM, Bragg RR. Onderstepoort J Vet Res; 1998 Dec; 65(4):317-20. PubMed ID: 10192845 [Abstract] [Full Text] [Related]
54. In vitro investigations on the action fosfomycin alone and in combination with other antibiotics on Pseudomonas aeruginosa and Serratia marcescens. Ullmann U, Lindemann B. Arzneimittelforschung; 1980 Dec; 30(8):1247-9. PubMed ID: 6776966 [Abstract] [Full Text] [Related]
55. [Growth curves of Escherichia coli submitted to fosfomycin]. Yourassowsky E, Van der Linden MP, Lismont MJ, Crokaert F. Pathol Biol (Paris); 1983 Jun; 31(6):512-4. PubMed ID: 6348659 [Abstract] [Full Text] [Related]